ERCP Biliary Cannulation Success Using ESGE Algorithm
BILINCE
Efficacy of ERCP Using ESGE Algorithm for Biliary Cannulation: a Multicenter Prospective Italian Study
1 other identifier
observational
200
1 country
1
Brief Summary
Papillary cannulation attempts have been shown to be an independent predictor of post-ERCP pancreatitis (PEP) when they are repeated more than 5 times or for 5 minutes or when the pancreatic duct is opacified or cannulated by using guidewire more than 1 time. In order to reduce complications, the 2016 ESGE guideline recommends a precise sequence of alternative cannulation techniques to the primary guidewire approach before exceeding the stated limits. However, there are no published data about the routinary application of this biliary cannulation algorithm. The investigators hypothesised that the ESGE algorithm predicts an increased cannulation success. Nevertheless, it's unclear if this benefit is also associated with a decreased risk of complications, mainly post-procedural pancreatitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 12, 2019
CompletedFirst Submitted
Initial submission to the registry
April 18, 2024
CompletedFirst Posted
Study publicly available on registry
April 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2025
CompletedMay 13, 2025
May 1, 2025
5.1 years
April 18, 2024
May 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Success of ERCP biliary cannulation rate
Success obtained with the different cannulation techniques according with the ESGE algorithm
At the end of the procedure.
Secondary Outcomes (1)
ERCP complication rates
At 0-72 hours, and at 30-days after the procedure.
Eligibility Criteria
Patients with either benign or primary/secondary malignant bile duct disease.
You may qualify if:
- patients \> 18 years of age;
- native papilla;
- signed Informed Consent;
You may not qualify if:
- previous biliary sphincterotomy;
- post-surgical ERCP;
- ampulloma or papilla involved by a tumor;
- pancreatic endotherapy;
- patients unable to give consent for the procedure;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- IRCCS San Raffaelelead
- Societa Italiana di Endoscopia Digestivacollaborator
Study Sites (1)
IRCCS OSpedale San Raffaele
Milan, Italy, 20132, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alberto Mariani, MD
IRCCS Ospedale San Raffaele
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 18, 2024
First Posted
April 24, 2024
Study Start
December 12, 2019
Primary Completion
December 31, 2024
Study Completion
March 30, 2025
Last Updated
May 13, 2025
Record last verified: 2025-05